Clinical Lab Test Jargon Could Spur Mistrust among Patients

By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue

LITTLE DETAILS CAN MAKE A BIG DIFFERENCE in not only how customers view a clinical laboratory, but also in ensur…

Read More

---

New Primary Care Providers May Change Who Buys & Who Orders Lab Tests

By Robert Michel | From the Volume XXVIII, No. 8 – June 14, 2021 Issue

This is an excerpt of a 2,445-word article in the June 14, 2021 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: This first installment in our series describes why market forces are at work to create a new playe…

Read More

---

New Players May Alter Who Buys & Who Orders Lab Tests

By Robert Michel | From the Volume XXVIII, No. 8 – June 14, 2021 Issue

CEO SUMMARY: This first installment in our series describes why market forces are at work to create a new player in healthcare that will transform the lab testing marketplace as we know it today in two ways. First, a new category of primary care providers has the potential to eventu…

Read More

---

Restitution and Guilty Plea in Two Lab Fraud Cases

By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue

CEO SUMMARY: In one case, owners and a sales rep agreed to pay restitution totaling almost $10 million. In the second case, three defendants pled guilty to federal charges involving payment or receipt of kickbacks and illegal inducements. A fourth defendent in this second case, a ph…

Read More

---

April 12, 2021 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue

One clinical laboratory company now says it provides COVID-19 testing services to all five of the major men’s professional sports leagues in the United States. On April 1, BioReference Laboratories, Inc. (BRLI), a division of Opko Health, announced a new agreement with Major League…

Read More

---

Despite COVID-19, Regular Lab Testing Expands

By R. Lewis Dark | From the Volume XXVIII, No. 4 – March 22, 2021 Issue

TIMES ARE GOOD FOR THE REGULAR RANGE of clinical laboratory and anatomic pathology testing services. Despite the COVID-19 pandemic, the daily number of routine test specimens is near pre-pandemic levels and certain sectors of lab testing—particularly genetic tests and some high-cost assays—are sh…

Read More

---

What Comes Next? Predictions on COVID-19 Test Volumes in 2021-22

By Robert Michel | From the Volume XXVIII, No. 4 – March 22, 2021 Issue

CEO SUMMARY: Incoming data show that the number of referrals for both COVID-19 tests and routine tests is in a decline that started in October and is continuing. This complicates the strategic planning for hospital/health system labs, independent labs, and pathology groups. They nee…

Read More

---

Academic, Commercial Collaboration for Testing

By Robert Michel | From the Volume XXVIII, No. 2 – February 8, 2021 Issue

CEO SUMMARY: In several important ways, this collaboration involving an academic clinical laboratory and a commercial company has paid big dividends, not just for the two partners, but also the parent university that oversaw the project. The two partners developed a SARS-CoV-2 test, t…

Read More

---

Two-Drop ‘Digital CBC’ Enters U.S. Market with FDA Clearance

By Robert Michel | From the Volume XXVIII, No. 1 – January 19, 2021 Issue

“We believe the ability to work with just two drops of blood, plus the…

Read More

---

UK Postpones Mass COVID Testing Plan Due to Questions of Accuracy

By Robert Michel | From the Volume XXVII, No. 18 – December 28, 2020 Issue

IN THE UNITED KINGDOM, A MASS COVID-19 TESTING PLAN called “Operation Moonshot” is on hold until at least the end of January. Under the plan, health ministers sought to increase daily SARS-CoV-2 testing from 430,000 to 10 million Englanders per day.  …

Read More

---